Exagen Inc’s recently made public that its 10% Owner NMSIC Co-Investment Fund, L.P. unloaded Company’s shares for reported $0.66 million on Nov 20 ’24. In the deal valued at $3.30 per share,200,000 shares were sold. As a result of this transaction, NMSIC Co-Investment Fund, L.P. now holds 2,108,958 shares worth roughly $10.59 million.
Then, Black Jeffrey G. bought 22,298 shares, generating $66,448 in total proceeds. Upon buying the shares at $2.98, the Chief Financial Officer now owns 274,492 shares.
Before that, ABALLI JOHN bought 24,305 shares. Exagen Inc shares valued at $68,297 were divested by the President and CEO at a price of $2.81 per share. As a result of the transaction, ABALLI JOHN now holds 689,799 shares, worth roughly $3.46 million.
KeyBanc Capital Markets downgraded its Exagen Inc [XGN] rating to a Sector weight from a an Overweight in a research note published recently. Canaccord Genuity began covering XGN with “Buy” recommendation on April 15, 2021. KeyBanc Capital Markets started covering the stock on November 10, 2020. It rated XGN as “an Overweight”.
Price Performance Review of XGN
On Tuesday, Exagen Inc [NASDAQ:XGN] saw its stock jump 29.38% to $5.02. Over the last five days, the stock has gained 23.65%. Exagen Inc shares have risen nearly 22.44% since the year began. Nevertheless, the stocks have risen 135.68% over the past one year. While a 52-week high of $6.22 was reached on 02/04/25, a 52-week low of $1.30 was recorded on 01/15/25. SMA at 50 days reached $4.24, while 200 days put it at $2.83.
Levels Of Support And Resistance For XGN Stock
The 24-hour chart illustrates a support level at 4.45, which if violated will result in even more drops to 3.88. On the upside, there is a resistance level at 5.47. A further resistance level may holdings at 5.92. The Relative Strength Index (RSI) on the 14-day chart is 67.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.34, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 12.74%. Stochastics %K at 81.53% indicates the stock is a selling.
How much short interest is there in Exagen Inc?
A steep rise in short interest was recorded in Exagen Inc stocks on 2024-10-31, growing by 36468.0 shares to a total of 52214.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 15746.0 shares. There was a rise of 69.84%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 08, 2020 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.
